Plus   Neg

Accenture Guides FY20 EPS Below Estimates; Boosts Dividend 10% - Quick Facts

While reporting financial results for the fourth quarter and fiscal 2019 on Thursday, Accenture Plc (ACN) initiated earnings and revenue growth outlook for the full-year 2020.

For fiscal 2020, the company now expects earnings in a range of $7.62 to $7.84 per share on revenue growth of 5.0 to 8.0 percent in local currency.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $7.96 per share on revenue growth of 6.7 percent to $46.13 billion for the year. Analysts' estimates typically exclude special items.

Additionally, Accenture also expects revenues for the first quarter of fiscal 2020 to be in the range of $10.9 billion to $11.2 billion, 5 percent to 8 percent growth in local currency. The street is looking for revenues of $11.26 billion for the quarter.

Julie Sweet, Accenture's chief executive officer, said, "As we look ahead to fiscal 2020, we will continue to be laser-focused on creating value for our clients, being a magnet for the best people in the industry and maximizing shareholder value."

As previously disclosed, the company is moving from a semi-annual to a quarterly schedule for dividend payments in fiscal 2020.

Accenture's Board of Directors has declared a quarterly cash dividend of $0.80 per share, payable on November 15, 2019 to shareholders of record at the close of business on October 17, 2019. The new quarterly dividend represents a 10 percent increase over the equivalent quarterly rate of fiscal 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Polaris Industries Inc. is recalling certain Ranger and General Utility, as well as All-Terrain vehicles citing risks of crash, the U.S. Consumer Product Safety Commission said in a statement. The Medina, Minnesota-based company has called back about 26,730 units of Model Year 2019 - 2020 Ranger XP 1000 & Model Year 2020 General XP 1000 Utility vehicles. Gilead Sciences Inc. (GILD) said Friday that the European Commission has granted conditional marketing authorization for Veklury or remdesivir as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19. FedEx is asking NFL team Washington Redskins to change its name for its racist connotations. The delivery services company, which is a major sponsor for the team, made the suggestion following increasing pressure from its investors amid the ongoing protests against racial injustice and inequality that arose from the killing of African-American George Floyd.
Follow RTT